Biomoneta Research Private Limited
IndiaFDA applicant, unverified
- Devices
- 1
What Biomoneta Research Private Limited makes
Biomoneta Research Private Limited manufactures the Biomoneta Avata Rx, a medical device designed for personalized health monitoring and analysis, likely incorporating biometric data collection and predictive analytics for clinical use.
The company’s portfolio is regulated under FDA’s Class II device classification, with the Biomoneta Avata Rx authorised via the 510(k) pathway. The device is listed in the FDA’s 510(k) registry, and the manufacturer is based in the United States.
Catalogue
Biomoneta Avata Rx Ref K251872
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Biomoneta Research Private Limited have in the registry?
The registry currently lists 1 device for Biomoneta Research Private Limited. Devices recorded under merged duplicate company entries are counted once.
Which registries list Biomoneta Research Private Limited's devices?
Among its 1 most recently registered device, Biomoneta Research Private Limited has devices listed in FDA 510(k) (1 device).
What risk classes do Biomoneta Research Private Limited's devices fall under?
Among its 1 most recently registered device, the classes recorded for Biomoneta Research Private Limited's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Biomoneta Research Private Limited in the registry?
The most recently registered devices listed for Biomoneta Research Private Limited include Biomoneta Avata Rx.